Cytori Cell Research Institute, Inc. (3750) Stock Statistics & Valuation Metrics

Cytori Cell Research Institute, Inc. has a market cap or net worth of JPY 7.14B. The enterprise value is JPY 7.13B.

Market Cap

JPY 7.14B

Enterprise Value

JPY 7.13B

Cytori Cell Research Institute, Inc. has 8,929,419 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

8,929,419

Owned by Insiders

―

Owned by Institutions

―

Cytori Cell Research Institute, Inc.’s return on equity (ROE) is -18.02 and return on invested capital (ROIC) is -639.62%.

Return on Equity (ROE)

-18.02

Return on Assets (ROA)

-1.08

Return on Invested Capital (ROIC)

-639.62%

Return on Capital Employed (ROCE)

-6.41

Revenue Per Employee

3.92M

Profits Per Employee

-30.53M

Employee Count

13

Asset Turnover

0.14

Inventory Turnover

0.62

The current PE Ratio of Cytori Cell Research Institute, Inc. is -12.75. Cytori Cell Research Institute, Inc.’s PEG ratio is -1.18.

PE Ratio

-12.75

PS Ratio

69.63

PB Ratio

-99.63

Price to FCF

0.00

Price to Operating Cash Flow

0.00

PEG Ratio

-1.18

In the last 12 months, Cytori Cell Research Institute, Inc. had revenue of 50.99M and earned -396.90M in profits. Earnings per share was -44.46.

Revenue

50.99M

Gross Profit

9.87M

Operating Income

-906.17M

Pretax Income

-397.85M

Net Income

-396.90M

EBITDA

-905.48M

Earnings Per Share (EPS)

-44.46

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow

0

Free Cash Flow

0

Free Cash Flow per Share

0.00

Cytori Cell Research Institute, Inc. pays an annual dividend of JPY 10.00, resulting in a dividend yield of ―

Dividend Per Share

JPY 10.00

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

0.00%

Earnings Yield

-7.85%

Beta

0.42

52-Week Price Change

-6.65%

50-Day Moving Average

798.28

200-Day Moving Average

815.62

Relative Strength Index (RSI)

57.34

Average Volume (3m)

7,425

Cytori Cell Research Institute, Inc. upcoming earnings date is Feb 05, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 13, 2026

Next Earnings Date

Feb 05, 2027

Ex-Dividend Date

Mar 30, 2020

Cytori Cell Research Institute, Inc. as a current ratio of 1.55, with Debt / Equity ratio of 0.00%

Current Ratio

1.55

Quick Ratio

1.25

Debt to Market Cap

0.00

Net Debt to EBITDA

0.14

Interest Coverage Ratio

-49.03

In the past 12 months, Cytori Cell Research Institute, Inc. has paid -948.00K in taxes.

Income Tax

-948.00K

Effective Tax Rate

0.00

Cytori Cell Research Institute, Inc. EV to EBITDA ratio is -8.46, with an EV/FCF ratio of 0.00.

EV to Sales

71.41

EV to EBITDA

-8.46

EV to Free Cash Flow

0.00

EV to Operating Cash Flow

0.00

Cytori Cell Research Institute, Inc. has JPY 67.10M in cash and marketable securities with JPY 250.00M in debt, giving a net cash position of -JPY 182.90M billion.

Cash & Marketable Securities

JPY 67.10M

Total Debt

JPY 250.00M

Net Cash

-JPY 182.90M

Net Cash Per Share

-JPY 20.48

Tangible Book Value Per Share

-JPY 8.03

Gross margin is 55.97%, with operating margin of -844.28%, and net profit margin of -546.29%.

Gross Margin

55.97%

Operating Margin

-844.28%

Pretax Margin

-544.45%

Net Profit Margin

-546.29%

EBITDA Margin

-843.78%

EBIT Margin

-844.28%

The average price target for Cytori Cell Research Institute, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

15.47%

EPS Growth Forecast

69.34%

Smart Score

―

AI Score

45